Live Breaking News & Updates on Forbesd porter

Repurposed ALS drug could slow gradual brain cell loss in Niemann-Pick disease type C1

Riluzole, a drug approved to treat amyotrophic lateral sclerosis (ALS), a disease affecting nerve cells controlling movement, could slow the gradual loss of a particular brain cell that occurs in Niemann-Pick disease type C1 (NPC1), a rare genetic disorder affecting children and adolescents, suggests a study in mice by scientists at the National Institutes of Health.

Forbesd-porter , Emily-henderson , Human-development , Ara-parseghian-medical-research-foundation , National-institutes-of-health , National-human-genome-research-institute , National-institute-of-arthritis , National-institutes , Kennedy-shriver-national-institute , Child-health , National-institute , Molecular-genetics

Repurposed ALS drug shows promise in mouse model of rare childhood genetic disorder

Repurposed ALS drug shows promise in mouse model of rare childhood genetic disorder
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Forbesd-porter , Human-development , Ara-parseghian-medical-research-foundation , National-institutes-of-health , National-human-genome-research-institute , National-institute-of-arthritis , National-institutes , Kennedy-shriver-national-institute , Child-health , National-institute , Molecular-genetics